Skip to main content
OpenTrials
Completed

NCT Number: NCT04962997

Health Status of Transgender Women in French Guiana and Paris (TransGuyane)

Assessing and comparing the life and health status of transgender or trans women in French Guiana and Paris. Conducting a questionnaire on physical, mental and sexual health, migration history, transition, and STI screening.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hopsitalier Uiversitaire de Bichat, Paris, France

Loading trial locations.

About this study

Transgender or trans women in French Guiana are not known to the hospital environment and rarely seek care: only about fifteen patients are followed up in the Infectious and Tropical Diseases Unit (UMIT) and the Adult Day Hospital (HDJA) of the Cayenne Hospital Center for Human Immunodeficiency Virus (HIV) infection. There is therefore a lack of knowledge of this population, of their health needs (physical, sexual and mental) but also a lack of assistance in the transition process. However, the violence suffered and the risks of infection are high among transgender women who frequently resort to sex work. In fact, they are said to carry the highest burden of HIV in the world, particularly in South America. The need for HIV prevention among transgender women in South America is great.

There is no bibliography of published works concerning transgender women in French Guiana, whereas there are more and more publications from countries that are geographically close (Brazil, Peru, United States), or even from metropolitan France. It is therefore necessary to address this issue in French Guiana. The population of transgender women followed up at the Bichat Hospital (for HIV infection or as part of a sexual health follow-up) represents one of the largest active files of transgender women in France and offers the opportunity to look at these two populations from a cross-sectional perspective.

The study will be cross-sectional and multicentric (Cayenne in French Guiana, Paris) and will include transgender women who have reached the age of majority and who agree to answer a questionnaire concerning their living and socio-economic conditions, their migration, their physical, sexual and mental health, and their transition process. Data relating to the search for Sexually Transmitted Infection STIs check-up as well as dermatological examination will be studied in particular with the agreement of the participants.

Data relating to the second consultation will be studied in particular (report of results) without systematic follow-up.

Non-interventional research (RIPH category 3). Cross-sectional observational multicentric study: at the CHC (Cayenne, French Guiana) and at Bichat Hospital (Paris).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Person identifying as a transgender woman
  • Consulting at Cayenne Hospital (French Guiana) or Bichat Hospital (Paris)
  • Between 07/2021 and 10/2022
  • Major
  • No opposition to the study
  • Absence of neurological or psychiatric disorders that prevented understanding of the study and free participation (sequelae of cerebral toxoplasmosis with aphasia, deaf and mute person, active neuro-meningeal opportunistic infections with cognitive impairment…)

Exclusion criteria

  • Minor
  • Refusal to participate and/or neurological or psychiatric disorder preventing understanding of the study
  • Not be able to answer questions in languages mastered by principal investigator (French, English, Spanish or Portuguese)
  • Person under guardianship or curatorship

Treatment and study plan

Data Collection

Other

Investigator will ensure the completion of a hetero-administered questionnaire which will be carried out in French, English, Portuguese or Spanish depending on the language spoken by the participant, including informations related to Demography and socio-economic conditions, Addictions, Work and studies, Housing, Health coverage, Gender and sexuality, Vulnerabilities and violence, Recourse to care, State of physical health, Mental Health, Prevention and Sexually Transmitted Infections (STIs), Checkup, Transition path and clinical complications and Dermatological problems.

Investigator will collect the data relating to the clinical examination, dermatological examination and the search for STIs (blood and / or urine) carried out in the routine care of the participant in a case report form (CRF).

The estimated duration of the interviews and the consultation is approximately 1 hour and 30 minutes per patient.

Primary outcomes

  1. Describe the frequency of violence suffered by transgender women treated in Cayenne or Paris

    Time frame: Day 0

    Frequency of psychological, physical and sexual violence suffered by transgender women

Secondary outcomes

  1. Describe the state of health of transgender women in Cayenne and Paris

    Time frame: Day 0

    Describe the state of health of transgender women based on the data collected

  2. Compare these results with those of the National Survey of Transgender Women Living with Human Immunodeficiency Virus

    Time frame: 17 months

    Compare these results with those of the National Survey of Transgender Women Living with Human Immunodeficiency Virus (Dr. Spire's Metropolitan Study on "Trans identity and Human Immunodeficiency Virus").

  3. Describe the state of health of transgender women in Cayenne and Paris

    Time frame: Day 1

    Describe the state of health of transgender women based on the data collected

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Cayenne

Other

Collaborators

  • Bichat Hospital

Registry information

Official study title

Health Status of Transgender Women in French Guiana and Paris: a Cross-sectional View (TransGuyane)

Acronym: TransGuyane

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Jul 15, 2021
Registry last updated
Oct 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.